There is a shift in the industry towards biopharmaceuticals, but there is still great demand for synthetic APIs. We catch up with Richard Hercek, Head of API Engineering and IPC, and Boris Petrusek, EU Project Manager, at Saneca Pharma to discuss the latest trends in small-molecule API manufacture.
False
False
Recommended
False
Related Content
AI and the Future of Formulation Development
November 19, 2026
5 min read
AI could soon allow scientists to model a drug’s journey from molecular structure through manufacturing to how it behaves in patient
Video: Sitting Down With… Delara Motlagh
November 13, 2026
1 min read
Fujifilm Cellular Dynamics’ Delara Motlagh discusses her path into cell and gene therapy, the challenges of scaling manufacturing, and the potential of iPSC technologies
Lonza to Acquire Five US CDMO Sites from Merck KGaA
November 11, 2026
2 min read
The deal adds viral vector, bioconjugation, payload-linker, and advanced drug-delivery capabilities to Lonza’s manufacturing network
Analytical Champions: Sarah O’Keeffe
November 10, 2026
14 min read
Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
